Your session is about to expire
← Back to Search
Cancer Screening Education for Rural Areas
N/A
Waitlist Available
Led By Anna Tosteson, ScD
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up survey administered immediately before educational intervention; approximately 3 months after initial participation in study
Awards & highlights
Study Summary
This trial will test an educational intervention to help people understand cancer screening.
Eligible Conditions
- Cancer
- Colorectal Cancer
- Lung Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ approximately 3 months after initial participation in study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 3 months after initial participation in study
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in colorectal cancer screening and other risk behavior intentions
Change in colorectal cancer screening behaviors
Change in knowledge related to colorectal cancer risk, prevention, and screening
+1 moreSecondary outcome measures
Change in knowledge related to lung cancer risk, prevention, and screening
Change in tobacco use frequency
Reach to current and former cigarette smokers
+2 moreTrial Design
4Treatment groups
Experimental Treatment
Group I: Experimental Arm 4Experimental Treatment1 Intervention
Patients identified by one or more healthcare systems to be due or overdue for colorectal cancer screening will be informed by their healthcare provider or healthcare system (e.g. via the healthcare system's patient portal) that they are due for screening and will be informed how to schedule an colorectal cancer screening related appointment (e.g. discussion with primary care provider about colorectal cancer screening options) along with the option to receive education about colorectal cancer screening. Patients who are interested in receiving education may view the education with or without participating in the research study. Patients who elect to be study participants will participate in consenting, eligibility screening, pre-test, post-test, and possible three- and six-month using a parallel structure to study arms two and three.
Group II: Experimental Arm 3Experimental Treatment1 Intervention
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via an age and geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online or telephone follow-up. This arms will serve as an experimental arm for assessing study aim 2 and as a control arm for study aim 1.
Group III: Experimental Arm 2Experimental Treatment1 Intervention
People with social medial accounts (e.g. Facebook) will receive a message about the study (e.g. via an age and geospatially targeted Facebook ad) and have the option to enroll in the study if meeting eligibility criteria, with some participating in online or telephone follow-up.
Group IV: Experimental Arm 1Experimental Treatment1 Intervention
Attendees at in-person events (e.g. health fairs) who meet eligibility criteria will be able to enroll and participate in-person, with some participating in online or telephone survey follow-up.
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
524 Previous Clinical Trials
2,542,959 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,654 Previous Clinical Trials
40,932,771 Total Patients Enrolled
Dartmouth CollegeOTHER
79 Previous Clinical Trials
1,415,192 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are between 45 and 74 years old when you join the study.Only residents of New Hampshire or Vermont between 45 and 75 years old can participate.You live in certain counties in New Hampshire or Vermont (Coos or Sullivan County, NH; Caledonia, Windsor, Windham, Orange, Orleans, Lamoille, or Essex County, VT).
Research Study Groups:
This trial has the following groups:- Group 1: Experimental Arm 4
- Group 2: Experimental Arm 1
- Group 3: Experimental Arm 3
- Group 4: Experimental Arm 2
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger